Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy
Authors:
- Kurt DegenhardtKDKurt Degenhardt
- Deirdre A. NelsonDNDeirdre A. Nelson
- Brian BeaudoinBBBrian Beaudoin
- Wilberto Nieves-NeiraWNWilberto Nieves-Neira
- Philippe BouilletPBPhilippe Bouillet
- Andreas VillungerAVAndreas Villunger
- Jerry M. AdamsJAJerry M. Adams
- Eileen WhiteEWEileen White
- 1 March 2005
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 7 (3) , 227-238
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Hypoxia and defective apoptosis drive genomic instability and tumorigenesisGenes & Development, 2004
- Role of Bim in the survival pathway induced by Raf in epithelial cellsOncogene, 2003
- Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1Nature, 2003
- The Bcl-2 family: roles in cell survival and oncogenesisOncogene, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Bcl-XL Protects BimEL-induced Bax Conformational Change and Cytochrome c Release Independent of Interacting with Bax or BimELJournal of Biological Chemistry, 2002
- ApoptosisCell, 2002
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent PathwayJournal of Biological Chemistry, 2001
- The Hallmarks of CancerCell, 2000